Brain Tumor FAQs
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

  • Question: Is the combination of Dendritic Cell Vaccine and oncolytic viruses possible and/or evaluated for the treatment of recurrent Glioblastoma Multiforme? If yes, what are the results, the pro's and con's, and where is this therapy evaluated?
  • Answer:02/21/2012
    No, in general, only one experimental treatment can be done at a time until they are approved, then you are allowed to mix them as much as you want.
DISCLAIMER
This site is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided at this web site is of a general nature and is not intended to take the place of a physician's advice. We encourage individuals to discuss what they find on this site with their healthcare providers. The answer above was provided by a volunteer, based solely on their experiances and thoughts. These volunteers do not get paid and are not responsible for the accuracy of their responses. IF you disagree with a response, let us know and we will look into it.


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites